Play all audios:
Despite initial teething problems, the number of clinically effective monoclonal antibodies is growing. Access through your institution Buy or subscribe This is a preview of subscription
content, access via your institution RELEVANT ARTICLES Open Access articles citing this article. * SUPPRESSING IMMUNOTHERAPY BY ORGAN-SPECIFIC TUMOR MICROENVIRONMENTS: WHAT IS IN THE BRAIN?
* Chenyu Zhang * & Dihua Yu _Cell & Bioscience_ Open Access 07 October 2019 * A RATIONAL APPROACH FOR CREATING PEPTIDES MIMICKING ANTIBODY BINDING * Sameer Sachdeva * , Hyun Joo *
… Xiaoling Li _Scientific Reports_ Open Access 30 January 2019 ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per
year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated
during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Kohler, G. & Milstein, C. Continuous
cultures of fused cells secreting antibody of predefined specificity. _Nature_ 256, 495–497 (1975). Article CAS Google Scholar * Carson, D.A. et al. Human lymphocyte hybridomas and
monoclonal antibodies. _Adv. Immunol._ 38, 275–311 (1986). Article CAS Google Scholar * Morrison, S.L. et al. Chimeric human antibody molecules: mouse antigen-binding domains with human
constant region domains. _Proc. Natl. Acad. Sci. USA_ 81, 6851–6855 (1984). Article CAS Google Scholar * Boulianne, G.L. et al. Production of functional chimaeric mouse/human antibody.
_Nature_ 312, 643–646 (1984). Article CAS Google Scholar * Jones, P.T. et al. Replacing the complementarity-determining regions in a human antibody with those from a mouse. _Nature_ 321,
522–525 (1986). Article CAS Google Scholar * Reichert, J.M. New biopharmaceuticals in the USA: trends in development and marketing approvals 1995–1999. _Trends Biotechnol._ 18, 364–369
(2000). Article CAS Google Scholar * DiMasi, J. Risks in new drug development: approval success rates for investigational drugs. _Clin. Pharmacol. Ther._ 69, 297–307 (2001). Article CAS
Google Scholar * Fox, S. Biopharmaceutical contract manufacturing: meeting increased demand for capacity. (HighTech Business Decisions, Moraga, CA; 2001). Download references AUTHOR
INFORMATION AUTHORS AND AFFILIATIONS * senior research fellow at the Tufts Center for the Study of Drug Development, Tufts, Boston, MA Janice M. Reichert Authors * Janice M. Reichert View
author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Reichert, J. Monoclonal
antibodies in the clinic. _Nat Biotechnol_ 19, 819–822 (2001). https://doi.org/10.1038/nbt0901-819 Download citation * Issue Date: September 2001 * DOI: https://doi.org/10.1038/nbt0901-819
SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to
clipboard Provided by the Springer Nature SharedIt content-sharing initiative